{"id":500013,"date":"2021-06-02T08:34:09","date_gmt":"2021-06-02T12:34:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\/"},"modified":"2021-06-02T08:34:09","modified_gmt":"2021-06-02T12:34:09","slug":"codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\/","title":{"rendered":"Codiak BioSciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">CAMBRIDGE, Mass., June  02, 2021  (GLOBE NEWSWIRE) &#8212; Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, today announced that its President and Chief Executive Officer, Douglas E. Williams, Ph.D., will participate in a virtual fireside chat at the Goldman Sachs 42<sup>nd<\/sup> Annual Global Healthcare Conference. Details are as follows:<\/p>\n<p>\n        <strong>Goldman Sachs 42<\/strong><br \/>\n        <sup><br \/>\n          <strong>nd<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Global Healthcare Virtual Conference <\/strong><br \/>\n        <br \/>Date: Thursday, June 10<br \/>Time: 3:00 PM ET<\/p>\n<p>A live webcast of the virtual fireside chat will be available on the Investors &amp; Media section of the Codiak website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-lHXEdBjjvsM4ujhNv8xn5uJCRVIAj-x2m0PRPAIHf1ymkrP1zbZxh8BmwY5bjAl85v_x-N861XlfDKCeOMoFg==\" rel=\"nofollow noopener\" target=\"_blank\">www.codiakbio.com<\/a>. An archived replay will be available for approximately 30 days following the fireside chat.<\/p>\n<p>\n        <strong>About Codiak BioSciences<\/strong><br \/>\n        <br \/>Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need. By leveraging the biology of exosomes as natural intercellular transfer mechanisms, Codiak has developed its proprietary engEx\u2122 Platform to expand upon the innate properties of exosomes to design, engineer and manufacture novel exosome therapeutic candidates. Codiak has utilized its engEx Platform to generate a deep pipeline of engineered exosomes aimed at treating a broad range of disease areas, spanning oncology, neuro-oncology, neurology, neuromuscular disease and infectious disease.<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NzAwMCM0MjIyNjgzIzIxNTcwMDI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/80333fe6-1246-4d1d-baa8-9389139c0959\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Investor Contact:\r\nChristopher Taylor\r\nVP, Investor Relations and Corporate Communications\r\nT: 617-949-4220\r\nE: investor@codiakbio.com\r\n\r\nMedia Contact:\r\nLindy Devereux\r\nScient PR\r\nT: 646-515-5730\r\nE: media@codiakbio.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., June 02, 2021 (GLOBE NEWSWIRE) &#8212; Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, today announced that its President and Chief Executive Officer, Douglas E. Williams, Ph.D., will participate in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference. Details are as follows: Goldman Sachs 42 nd Annual Global Healthcare Virtual Conference Date: Thursday, June 10Time: 3:00 PM ET A live webcast of the virtual fireside chat will be available on the Investors &amp; Media section of the Codiak website at www.codiakbio.com. An archived replay will be available for approximately 30 days following the fireside chat. About Codiak BioSciences &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Codiak BioSciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-500013","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Codiak BioSciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Codiak BioSciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., June 02, 2021 (GLOBE NEWSWIRE) &#8212; Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, today announced that its President and Chief Executive Officer, Douglas E. Williams, Ph.D., will participate in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference. Details are as follows: Goldman Sachs 42 nd Annual Global Healthcare Virtual Conference Date: Thursday, June 10Time: 3:00 PM ET A live webcast of the virtual fireside chat will be available on the Investors &amp; Media section of the Codiak website at www.codiakbio.com. An archived replay will be available for approximately 30 days following the fireside chat. About Codiak BioSciences &hellip; Continue reading &quot;Codiak BioSciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-02T12:34:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NzAwMCM0MjIyNjgzIzIxNTcwMDI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Codiak BioSciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference\",\"datePublished\":\"2021-06-02T12:34:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\\\/\"},\"wordCount\":236,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0NzAwMCM0MjIyNjgzIzIxNTcwMDI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\\\/\",\"name\":\"Codiak BioSciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0NzAwMCM0MjIyNjgzIzIxNTcwMDI=\",\"datePublished\":\"2021-06-02T12:34:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0NzAwMCM0MjIyNjgzIzIxNTcwMDI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0NzAwMCM0MjIyNjgzIzIxNTcwMDI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Codiak BioSciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Codiak BioSciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\/","og_locale":"en_US","og_type":"article","og_title":"Codiak BioSciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference - Market Newsdesk","og_description":"CAMBRIDGE, Mass., June 02, 2021 (GLOBE NEWSWIRE) &#8212; Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, today announced that its President and Chief Executive Officer, Douglas E. Williams, Ph.D., will participate in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference. Details are as follows: Goldman Sachs 42 nd Annual Global Healthcare Virtual Conference Date: Thursday, June 10Time: 3:00 PM ET A live webcast of the virtual fireside chat will be available on the Investors &amp; Media section of the Codiak website at www.codiakbio.com. An archived replay will be available for approximately 30 days following the fireside chat. About Codiak BioSciences &hellip; Continue reading \"Codiak BioSciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-02T12:34:09+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NzAwMCM0MjIyNjgzIzIxNTcwMDI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Codiak BioSciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference","datePublished":"2021-06-02T12:34:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\/"},"wordCount":236,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NzAwMCM0MjIyNjgzIzIxNTcwMDI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\/","name":"Codiak BioSciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NzAwMCM0MjIyNjgzIzIxNTcwMDI=","datePublished":"2021-06-02T12:34:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NzAwMCM0MjIyNjgzIzIxNTcwMDI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NzAwMCM0MjIyNjgzIzIxNTcwMDI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/codiak-biosciences-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-virtual-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Codiak BioSciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/500013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=500013"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/500013\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=500013"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=500013"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=500013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}